|
Novus Biologicals
cd11b ![]() Cd11b, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icrf44/pm39038918-181-11-25?v=Novus+Biologicals Average 92 stars, based on 1 article reviews
cd11b - by Bioz Stars,
2026-08
92/100 stars
|
Buy from Supplier |
|
Novus Biologicals
icrf44 ![]() Icrf44, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icrf44/bio_rxiv__2024__09__08__611916-188-28-30?v=Novus+Biologicals Average 92 stars, based on 1 article reviews
icrf44 - by Bioz Stars,
2026-08
92/100 stars
|
Buy from Supplier |
|
fluidigm
cd11b mac 1 ![]() Cd11b Mac 1, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icrf44/pmc10521424-58-2-7?v=fluidigm Average 94 stars, based on 1 article reviews
cd11b mac 1 - by Bioz Stars,
2026-08
94/100 stars
|
Buy from Supplier |
|
fluidigm
icrf44 ![]() Icrf44, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icrf44/pmc07963480-39-13-5?v=fluidigm Average 94 stars, based on 1 article reviews
icrf44 - by Bioz Stars,
2026-08
94/100 stars
|
Buy from Supplier |
|
Becton Dickinson
mouse anti-human cd11b-v450 icrf44 ![]() Mouse Anti Human Cd11b V450 Icrf44, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/icrf44/pmc08837256-64-8-14?v=Becton+Dickinson Average 90 stars, based on 1 article reviews
mouse anti-human cd11b-v450 icrf44 - by Bioz Stars,
2026-08
90/100 stars
|
Buy from Supplier |
|
The CD11b Antibody (ICRF44) [DyLight 594] from Novus is a CD11b antibody to CD11b. This antibody reacts with Human. The CD11b antibody has been validated for the following applications: Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-reported.
|
Buy from Supplier |
|
Isotype Note IgG1 kappa Host Species Note Mouse Reactivity Note Human Pig Baboon Chimpanzee
|
Buy from Supplier |
|
Isotype Note IgG1 kappa Host Species Note Mouse Reactivity Note Human Pig Baboon Chimpanzee
|
Buy from Supplier |
|
The CD11b Antibody (ICRF44) [PE/Atto594] from Novus is a CD11b antibody to CD11b. This antibody reacts with Human. The CD11b antibody has been validated for the following applications: Flow Cytometry.
|
Buy from Supplier |
|
The CD11b Antibody (ICRF44) [DyLight 550] from Novus is a CD11b antibody to CD11b. This antibody reacts with Human. The CD11b antibody has been validated for the following applications: Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-reported.
|
Buy from Supplier |
|
The CD11b Antibody (ICRF44) [Janelia Fluor® 549] from Novus is a CD11b antibody to CD11b. This antibody reacts with Human. The CD11b antibody has been validated for the following applications: Flow Cytometry, Immunohistochemistry, Immunocytochemistry, CyTOF-reported.
|
Buy from Supplier |
Image Search Results
Journal: Journal for immunotherapy of cancer
Article Title: Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases.
doi: 10.1136/jitc-2024-008837
Figure Lengend Snippet: Figure 2 Modulation of liver myeloid and lymphoid compartments by nelitolimod via pressure-enabled drug delivery was preserved in combination with Sys or SQ checkpoint inhibitor. Liver of tumor-bearing mice were harvested 10 days post- treatment. CD45+ cells were isolated from non-parenchymal cells. (A) MDSC cell population (CD11b+Gr1+), (B) monocytic MDSCs (M-MDSC; CD11b+Ly6C+/hiLy6G−/lo), (C) dendritic (CD11c+) cells, (D) B cells (B220+), (E) T cells (CD3+) and (F) M1- like macrophage (F/4/80+CD38+EGR2−) were quantified by flow cytometry. (G) i (a–h) Tumors were isolated from each group, OCT-mounted tissues were sectioned, fixed, and stained for CD3 (green), CD8 (red), CD11b (green), and Gr1 (red). (G) ii–iii Quantification of CD11b+Gr1+ MDSCs and CD3+CD8+T cells and from tumors of mice were performed across five fields/mouse and n=3 mice were used per group. Scale (20 µm). Animal data were presented as mean±SEM from and n was mentioned in the individual graph. One-way analysis of variance was performed to determine statistical differences among multiple groups. MDSC, myeloid-derived suppressor cells; M-MDSC, monocytic MDSC; G-MDSC, granulocytic MDSC; OCT, Optimal temperature cutting compound; DAPI, 4′,6-Diamidino-2-phenylindole; SQ, subcutaneous; Sys, systemic; Veh, vehicle.
Article Snippet: Primary antibodies and their corresponding clones used for immunofluorescence (IF) staining:
Techniques: Isolation, Flow Cytometry, Staining, Derivative Assay
Journal: Journal of Neuroinflammation
Article Title: Extended interval dosing of ocrelizumab modifies the repopulation of B cells without altering the clinical efficacy in multiple sclerosis
doi: 10.1186/s12974-023-02900-z
Figure Lengend Snippet: Antibodies for CyTOF
Article Snippet: 209Bi ,
Techniques: Concentration Assay
Journal: eLife
Article Title: Seroconversion stages COVID19 into distinct pathophysiological states
doi: 10.7554/eLife.65508
Figure Lengend Snippet:
Article Snippet: Antibody , Anti-Human CD11b ,
Techniques: Staining, Biomarker Discovery, Software